JADE101 Phase 1 healthy volunteer interim data expected in the second quarter of 2026; Phase 2 clinical trial in patients with IgA nephropathy expected to begin mid-2026 with preliminary data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results